Gene Inactivation of Proprotein Convertase Subtilisin/Kexin Type 9 Reduces Atherosclerosis in Mice-Reference-Cited by-同舟云学术

Gene Inactivation of Proprotein Convertase Subtilisin/Kexin Type 9 Reduces Atherosclerosis in Mice

Published:2012-02-21 Issue:7 Volume:125 Page:894-901
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Denis Maxime¹,Marcinkiewicz Jadwiga¹,Zaid Ahmed¹,Gauthier Dany¹,Poirier Steve¹,Lazure Claude¹,Seidah Nabil G.¹,Prat Annik¹

Affiliation:

1. From the Laboratory of Biochemical Neuroendocrinology (M.D., J.M., A.Z., S.P., N.G.S., A.P.) and Laboratory of Neuropeptide Structure and Metabolism (D.G., C.L.), Clinical Research Institute of Montreal, Montreal, Canada. Dr Zaid is presently at the Department of Biochemistry, Faculty of Medicine, Tripoli University, Tripoli, Libya.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference47 articles.

1. Projections of Global Mortality and Burden of Disease from 2002 to 2030

2. Atherosclerosis

3. Inflammation in atherosclerosis

Cited by 196 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Patients Following Acute Coronary Syndromes: From Lipid Lowering and Plaque Stabilization to Improved Outcomes;Journal of Clinical Medicine;2024-08-25

2. PCSK9 and Coronary Artery Plaque—New Opportunity or Red Herring?;Current Atherosclerosis Reports;2024-08-16

3. The impact of histone lactylation on the tumor microenvironment and metabolic pathways and its potential in cancer therapy;Genes & Genomics;2024-08-10

4. The role of proprotein convertase subtilisin/kexin 9 (PCSK9) in macrophage activation: a focus on its LDL receptor-independent mechanisms;Frontiers in Cardiovascular Medicine;2024-08-01

5. Global trends and research hotspots of PCSK9 and cardiovascular disease: a bibliometric and visual analysis;Frontiers in Cardiovascular Medicine;2024-06-03